Roula Qaqish

Roula Qaqish is the Franchise Head for US Medical Affairs in Women's Cancers at AstraZeneca, a position held since 2022. Prior to this, Roula served as the Senior Vice President at Nektar Therapeutics, where they led the global medical affairs organization for the Oncology and Immunology portfolio. With a rich background in pharmaceutical and clinical settings, Roula has held leadership roles at AbbVie, Pharmacyclics, and Abbott, where they contributed significantly to oncology and infectious diseases. Roula's academic credentials include a Doctor of Pharmacy from Northeastern University, along with postdoctoral training in Pharmacotherapy and a residency in Pharmacy Practice.